We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current XLVE market cap is 0. The company's latest EPS is CAD and P/E is N/A.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Revenue | 0 | -218k |
Operating Income | 0 | 0 |
Net Income | 0 | -507k |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Assets | 0 | 6.5M |
Total Liabilities | 0 | 89k |
Total Equity | 0 | 6.41M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Operating | N/A | -6.51M |
Investing | N/A | N/A |
Financing | N/A | 6.96M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.06 (0.77%) |
Company Name | Mulvihill US Health Care Enhanced Yield ETF |
Address |
121 king street west toronto, ontario M5H 3T9 |
Website | https:// |
Industry | investment advice (6282) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions